Alembic Limited

Equities

ALEMBICLTD

INE426A01027

Real Estate Development & Operations

Market Closed - Bombay S.E. Other stock markets 06:24:35 2024-04-26 am EDT			5-day change	1st Jan Change
94.2 ^INR	-0.65%		+1.80%	+3.96%

Apr. 18	Alembic Pharmaceuticals Board to Consider Dividend for Fiscal 2024; Shares Drop 3%	MT
Apr. 02	Alembic Pharmaceuticals Gets US FDA Tentative Nod for Generic Breast Cancer Treatment	MT

Alembic Limited Announces Company Secretary & Compliance Officer Changes

August 10, 2023 at 06:45 am EDT

Alembic Limited announced resignation of Mr. Drigesh Mittal (ICSI Membership No. F8213) with effect from August 21, 2023 and appointment of Mr. Keval Thakkar (ICSI Membership No. A39127) with effect from September 1, 2023 as the Company Secretary & Compliance Officer (Key Managerial Personnel) of the Company.

Mr. Keval Thakkar is an Associate Member of Institute of Company Secretaries of India with post qualification experience of 8 years including 4 years at Alembic group with experience in corporate secretarial, compliance and corporate restructuring.

Latest news about Alembic Limited

Alembic Pharmaceuticals Board to Consider Dividend for Fiscal 2024; Shares Drop 3%	Apr. 18	MT
Alembic Pharmaceuticals Gets US FDA Tentative Nod for Generic Breast Cancer Treatment	Apr. 02	MT
Alembic Limited Announces Cessation of C. P. Buch as an Independent Director	Apr. 01	CI
Alembic Pharmaceuticals' Oncology Plant in Gujarat, India Gets One Observation from US FDA	Mar. 11	MT
Crisil Keeps AA+ Rating on Alembic Pharmaceuticals' Bank Loans with Stable Outlook	Mar. 08	MT
ICRA Affirms AA- Rating on Alembic's Bank Financing; Outlook Stable	Feb. 29	MT
Indian shares seen muted tracking broader Asian equities	Feb. 25	RE
Alembic Pharmaceuticals Fully Resumes Operations at Manufacturing Unit in South Sikkim, India	Feb. 23	MT
Alembic Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 14	CI
Alembic Pharmaceuticals' Consolidated Net Profit Jumps in Fiscal Q3; EPS Tops Estimates	Feb. 06	MT
Alembic Pharmaceuticals' Consolidated Profit Climbs in Fiscal Q3, EPS Beats Estimates	Feb. 06	MT
India's Alembic Pharma beats Q3 profit view on strong domestic, US sales	Feb. 05	RE
North American Morning Briefing : Jobs Report Tops -2-	Feb. 02	DJ
North American Morning Briefing : Microsoft Kicks -2-	Jan. 30	DJ
North American Morning Briefing : Stock Futures -2-	Jan. 23	DJ
Alembic Pharmaceuticals Expects Operations at Sikkim, India Units to Be Restores in Two Months	Jan. 05	MT
Alembic Pharmaceuticals Extends Corporate Guarantee to US-Based Arm to Secure Credit	Jan. 02	MT
North American Morning Briefing : Stock Futures -2-	Nov. 16	DJ
Alembic Pharmaceuticals Logs Slightly Higher Consolidated Profit in Fiscal Q2; EPS Misses Estimates	Nov. 08	MT
India's Alembic Pharma Q2 profit roughly in-line with estimates	Nov. 07	RE
North American Morning Briefing : Stocks Look to -2-	Nov. 06	DJ
Alembic Limited Appoints Dr. Girish Hirode as an Independent Director of the Company	23-08-10	CI
Alembic Limited Announces Company Secretary & Compliance Officer Changes	23-08-10	CI
Alembic Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-10	CI
Alembic Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-10	CI

Chart Alembic Limited

Duration

Period

More charts

Company Profile

Alembic Limited is an India-based company engaged in the business of development, manufacturing, and marketing of pharmaceutical products. The Company's segments include the Active Pharmaceutical Ingredients Business and the Real Estate Business. The Active Pharmaceutical Ingredients Business is engaged in the manufacturing and marketing of fermentation and chemistry based active pharmaceutical ingredients (API). The Real Estate Business is engaged in the construction of residential and commercial real estate projects and project management and marketing consultancy. The Company provides certain commercial properties on a lease basis to various tenants. The Company is also engaged in research and development activities in Vadodara. It is also engaged in power generation through co-generation.

Sector

Real Estate Development & Operations

Calendar

2024-05-15 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Real Estate Development & Operations

	1st Jan change	Capi.
ALEMBIC LIMITED	+3.96%	290M
MITSUI FUDOSAN CO., LTD.	+36.16%	27.94B
SUN HUNG KAI PROPERTIES LIMITED	-13.74%	26.97B
DLF LIMITED	+25.00%	26.95B
CHINA RESOURCES LAND LIMITED	-0.71%	25.32B
MITSUBISHI ESTATE CO., LTD.	+44.49%	22.58B
EMAAR PROPERTIES	+2.78%	19.59B
CHINA OVERSEAS LAND & INVESTMENT LTD.	+1.45%	19.52B
SUMITOMO REALTY & DEVELOPMENT CO., LTD.	+28.54%	16.23B
CK ASSET HOLDINGS LIMITED	-14.80%	14.98B

Other Real Estate Development & Operations